Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials

Authors:	Robert?J?van Soest Email author" target="_blank">Ronald?de Wit Email author

Institution:	1.Departments of Urology,Erasmus University Medical Center and Cancer Institute,Rotterdam,The Netherlands;2.Department of Medical Oncology, Erasmus University Medical Center and Cancer Institute,Rotterdam,The Netherlands

Abstract:

Keywords:
本文献已被 SpringerLink 等数据库收录！